Targeting SHP2 phosphatase in Myeloproliferative Neoplasms
Targeting SHP2 phosphatase in Myeloproliferative Neoplasms |
|
https://doi.org/10.18632/oncotarget.665
Raghuveer Singh Mali,
Rebecca Chan,
and Reuben Kapur
|
| 1049-1051 |
p53 as a target in myeloproliferative neoplasms
p53 as a target in myeloproliferative neoplasms |
|
https://doi.org/10.18632/oncotarget.719
Min Lu,
and Ronald Hoffman
|
| 1052-1053 |
Inhibiting the molecular evolution of cancer through HSP90
Inhibiting the molecular evolution of cancer through HSP90 |
|
https://doi.org/10.18632/oncotarget.738
Ana Sofia Martins,
Faith E. Davies,
and Paul Workman
|
| 1054-1056 |
Regulation of p53 by Helicobacter pylori
Regulation of p53 by Helicobacter pylori |
|
https://doi.org/10.18632/oncotarget.698
Alexander Zaika,
Jinxiong Wei,
Jennifer Noto,
and Richard Peek, Jr
|
| 1057-1058 |
HLX in AML: novel prognostic and therapeutic target
HLX in AML: novel prognostic and therapeutic target |
|
https://doi.org/10.18632/oncotarget.705
Ashley Pandolfi,
and Ulrich Steidl
|
| 1059-1060 |
Exploiting the mTOR paradox for disease prevention
Exploiting the mTOR paradox for disease prevention |
|
https://doi.org/10.18632/oncotarget.712
Ramiro Iglesias-Bartolome,
and J. Silvio Gutkind
|
| 1061-1063 |
Too much AKT turns PAX3-FKHR dead: A prospect of novel therapeutic strategy for alveolar rhabdomyosarcoma
Too much AKT turns PAX3-FKHR dead: A prospect of novel therapeutic strategy for alveolar rhabdomyosarcoma |
|
https://doi.org/10.18632/oncotarget.713
Mathivanan Jothi,
and Asoke K. Mal
|
| 1064-1065 |
Burkitt lymphomagenesis linked to MYC plus PI3K in germinal center B cells
Burkitt lymphomagenesis linked to MYC plus PI3K in germinal center B cells |
|
https://doi.org/10.18632/oncotarget.726
Sandrine Sander,
and Klaus Rajewsky
|
| 1066-1067 |
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Cascade Inhibitors: How Mutations Can Result in Therapy Resistance and How to Overcome Resistance
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Cascade Inhibitors: How Mutations Can Result in Therapy Resistance and How to Overcome Resistance |
|
https://doi.org/10.18632/oncotarget.659
James Andrew McCubrey,
Linda S. Steelman,
William H. Chappell,
Stephen L. Abrams,
Richard A. Franklin,
Giuseppe Montalto,
Melchiorre Cervello,
Massimo Libra,
Saverio Candido,
Grazia Malaponte,
Maria C. Mazzarino,
Paolo Fagone,
Ferdinando Nicoletti,
Jörg Bäsecke,
Sanja Mijatovic,
Danijela Maksimovic-Ivanic,
Michele Milella,
Agostino Tafuri,
Francesca Chiarini,
Camilla Evangelisti,
Lucio Cocco,
and Alberto M. Martelli
|
| 1068-1111 |
Disulfiram, a drug widely used to control alcoholism, suppresses self-renewal of glioblastoma and overrides resistance to temozolomide
Disulfiram, a drug widely used to control alcoholism, suppresses self-renewal of glioblastoma and overrides resistance to temozolomide |
|
https://doi.org/10.18632/oncotarget.604
Joanna Triscott,
Cathy Lee,
Kaiji Hu,
Abbas Fotovati,
Rachel Berns,
Mary Pambid,
Margaret Luk,
Richard E Kast,
Esther Kong,
Eric Toyota,
Stephen Yip,
Brian Toyota,
and Sandra E Dunn
|
| 1112-1123 |
High-Throughput Chemical Screens Identify Disulfiram as an Inhibitor of Human Glioblastoma Stem Cells
High-Throughput Chemical Screens Identify Disulfiram as an Inhibitor of Human Glioblastoma Stem Cells |
|
https://doi.org/10.18632/oncotarget.707
Parvinder Hothi,
Timothy J. Martins,
LiPing Chen,
Loic Deleyrolle,
Jae-Geun Yoon,
Brent Reynolds,
and Greg Foltz
|
| 1124-1136 |
High cytidine deaminase expression in the liver provides sanctuary for cancer cells from decitabine treatment effects
High cytidine deaminase expression in the liver provides sanctuary for cancer cells from decitabine treatment effects |
|
https://doi.org/10.18632/oncotarget.597
Quteba Ebrahem,
Reda Z Mahfouz,
Kwok Peng Ng,
and Yogen Saunthararajah
|
| 1137-1145 |
FOXP3, a novel glioblastoma oncosuppressor, affects proliferation and migration
FOXP3, a novel glioblastoma oncosuppressor, affects proliferation and migration |
|
https://doi.org/10.18632/oncotarget.644
Véronique Frattini,
Federica Pisati,
Maria Carmela Speranza,
Pietro Luigi Poliani,
Gianmaria Frigé,
Gabriele Cantini,
Dimos Kapetis,
Manuela Cominelli,
Alessandra Rossi,
Gaetano Finocchiaro,
and Serena Pellegatta
|
| 1146-1157 |
Heat Shock Protein 90 is overexpressed in high-risk myelodysplastic syndromes and associated with higher expression and activation of Focal Adhesion Kinase
Heat Shock Protein 90 is overexpressed in high-risk myelodysplastic syndromes and associated with higher expression and activation of Focal Adhesion Kinase |
|
https://doi.org/10.18632/oncotarget.557
Pascale Flandrin-Gresta,
Francoise Solly,
Carmen Mariana Aanei,
Jerome Cornillon,
Emmanuelle Tavernier,
Nathalie Nadal,
Franck Morteux,
Denis Guyotat,
Eric Wattel,
and Lydia Campos
|
| 1158-1168 |
Targeting JNK-interacting-protein-1 (JIP1) sensitises osteosarcoma to doxorubicin
Targeting JNK-interacting-protein-1 (JIP1) sensitises osteosarcoma to doxorubicin |
|
https://doi.org/10.18632/oncotarget.600
Jantine Posthuma De Boer,
Pim W. van Egmond,
Marco N. Helder,
Renée X. de Menezes,
Anne-Marie Cleton-Jansen,
Jeroen A.M. Beliën,
Henk M.W. Verheul,
Barend J. van Royen,
Gert-Jan J.L. Kaspers,
and Victor W. van Beusechem
|
| 1169-1181 |
Up-regulation of c-MYC and SIRT1 expression correlates with malignant transformation in the serrated route to colorectal cancer
Up-regulation of c-MYC and SIRT1 expression correlates with malignant transformation in the serrated route to colorectal cancer |
|
https://doi.org/10.18632/oncotarget.628
Lydia Kriegl,
Michael Vieth,
Thomas Kirchner,
and Antje Menssen
|
| 1182-1193 |
Whole-exome sequencing identifies ATRX mutation as a key molecular determinant in lower-grade glioma
Whole-exome sequencing identifies ATRX mutation as a key molecular determinant in lower-grade glioma |
|
https://doi.org/10.18632/oncotarget.689
Kasthuri Kannan,
Akiko Inagaki,
Joachim Silber,
Daniel Gorovets,
Jianan Zhang,
Edward R. Kastenhuber,
Adriana Heguy,
John H. Petrini,
Timothy A. Chan,
and Jason T. Huse
|
| 1194-1203 |
Reactivation of codogenic endogenous retroviral (ERV) envelope genes in human endometrial carcinoma and prestages: Emergence of new molecular targets.
Reactivation of codogenic endogenous retroviral (ERV) envelope genes in human endometrial carcinoma and prestages: Emergence of new molecular targets. |
|
https://doi.org/10.18632/oncotarget.679
Pamela L. Strissel,
Matthias Ruebner,
Falk Thiel,
David Wachter,
Arif B. Ekici,
Friedericke Wolf,
Franziska Thieme,
Klemens Ruprecht,
Matthias W. Beckmann,
and Reiner Strick
|
| 1204-1219 |
The mitochondrial citrate transporter, CIC, is essential for mitochondrial homeostasis.
The mitochondrial citrate transporter, CIC, is essential for mitochondrial homeostasis. |
|
https://doi.org/10.18632/oncotarget.714
Olga Catalina-Rodriguez,
Vamsi K. Kolukula,
York Tomita,
Anju Preet,
Ferdinando Palmieri,
Anton Wellstein,
Stephen Byers,
Amato J. Giaccia,
Eric Glasgow,
Chris Albanese,
and Maria Laura Avantaggiati
|
| 1220-1235 |
Effects of Ectopic Expression of NGAL on Doxorubicin Sensitivity.
Effects of Ectopic Expression of NGAL on Doxorubicin Sensitivity. |
|
https://doi.org/10.18632/oncotarget.691
William H Chappell,
Stephen L. Abrams,
Richard A Franklin,
Giuseppe Montalto,
Melchiorre Cervello,
Alberto M Martelli,
Saverio Candido,
Massimo Libra,
Jerry Polesel,
Renato Talamini,
Ralph Arlinghaus,
Linda S Steelman,
and James A McCubrey
|
| 1236-1245 |
DNA-demethylating and anti-tumor activity of synthetic miR-29b mimics in multiple myeloma
DNA-demethylating and anti-tumor activity of synthetic miR-29b mimics in multiple myeloma |
|
https://doi.org/10.18632/oncotarget.675
Nicola Amodio,
Marzia Leotta,
Dina Bellizzi,
Maria Teresa Di Martino,
Patrizia D'Aquila,
Marta Lionetti,
Fernanda Fabiani,
Emanuela Leone,
Anna Maria Gullà,
Giuseppe Passarino,
Michele Caraglia,
Massimo Negrini,
Antonino Neri,
Antonio Giordano,
Pierosandro Tagliaferri,
and Pierfrancesco Tassone
|
| 1246-1258 |
